When Should Researchers Voluntarily Pause a Study for Ethical Reasons?

When Should Researchers Stop Temporarily Even Though Approval Is Still Active?

Your ethics approval has not been suspended. No regulator has ordered the study to stop. Yet something has changed: participants are reacting in a way you did not expect, a consent problem may have affected several enrollments, a data-security incident has occurred, or repeated protocol departures suggest that the research team no longer fully understands what is happening.

Must researchers continue until an ethics committee formally tells them otherwise?

No. Ethics approval establishes authorization to conduct approved research, but it does not require researchers to keep recruiting or performing discretionary research procedures when emerging information creates a credible participant-protection concern that needs to be understood first. In some circumstances, temporarily pausing all or part of the study is the more defensible response while the problem is assessed.

Pause When Continuing Could Compound an Unresolved Ethical or Safety Problem

A Voluntary Pause Is a Protective Measure, Not an Admission That the Study Has Failed

You Do Not Need to Wait for Formal Suspension to Act Conservatively

Researchers are responsible for participant protection during the conduct of the study, not merely for responding to instructions from an ethics committee. When credible information raises a significant unresolved concern, continuing unchanged while waiting for someone else to intervene can expose additional participants to the same problem.

OHRP guidance on unanticipated problems identifies suspension of new enrollment and suspension of research procedures in currently enrolled participants among the corrective actions that may need to be considered when new information suggests greater research-related risk than previously recognized. Under that U.S. framework, the appropriate response depends on the nature of the problem rather than on a rule that every unexpected event requires a halt.

Other jurisdictions and institutions may use different terminology and procedures. The broader practical principle is that investigators should not knowingly continue exposing additional participants to a potentially consequential unresolved problem simply because formal approval remains technically active.

New Safety Information Is One of the Clearest Reasons to Consider a Pause

A study may reveal an adverse event, pattern of events, or other information suggesting that participants face greater risk than researchers and the ethics committee previously understood.

Under OHRP guidance, an unanticipated problem generally involves an incident, experience, or outcome that is unexpected, related or possibly related to the research, and suggests greater risk of harm than was previously known or recognized. Such problems can warrant changes to monitoring, eligibility, consent, enrollment, or research procedures.

ICH E6(R3) similarly requires prompt communication to the IRB or independent ethics committee of new information that may adversely affect participant safety or trial conduct in clinical trials.

A pause can prevent additional exposure while researchers determine whether the risk is real, how large it is, and whether the study can be modified safely.

A Consent Problem Can Justify Pausing New Enrollment

Suppose researchers discover that participants have been receiving an outdated consent form missing important information. If the problem appears systemic, continuing to enroll new participants using a consent process whose adequacy is uncertain would compound the issue.

Temporarily pausing new enrollment while the team identifies affected participants, verifies the current materials, and seeks ethics guidance may be more appropriate than continuing and hoping the problem proves unimportant.

This is especially relevant when the wrong approved document version has been used and the substantive difference between versions could affect participants' understanding or willingness to participate.

A Privacy or Confidentiality Incident May Require More Than Fixing the Technical Problem

Suppose identifiable research data are inadvertently exposed because a storage configuration was incorrect. Correcting the setting may stop the immediate exposure, but researchers still need to determine what information was accessible, to whom, for how long, and whether the same system remains suitable for collecting new participant data.

If the answer is uncertain, temporarily stopping the affected data collection or transfer process can prevent the incident from expanding while technical, institutional, ethics, and legal requirements are assessed.

A pause should target the affected activity where possible. A confidentiality problem in one data-transfer system does not automatically mean every unrelated aspect of the research must cease.

Repeated Protocol Deviations Can Signal That Continuing Normally Is No Longer Sensible

One isolated departure may be handled through the applicable deviation process. A recurring pattern can indicate a deeper problem: staff may not understand the protocol, a procedure may be unrealistic, version control may have failed, or actual practice may have evolved beyond what was approved.

When the study has begun drifting from the approved protocol, temporarily stopping the affected activity may prevent additional departures while researchers map the problem and determine whether training, corrective action, or an amendment is needed.

Uncertainty Itself Can Sometimes Justify a Short Pause

Researchers do not always know immediately whether an event is serious. There may be conflicting information, incomplete records, uncertain causality, or disagreement about what the protocol requires.

A short, proportionate pause can be justified when the cost of waiting is modest but the consequence of continuing incorrectly could be substantial. This is an application of prudent risk management rather than a claim that uncertainty automatically makes research unethical.

The threshold should remain meaningful. If every minor ambiguity stops a study, research becomes unworkable. The relevant question is whether continuing during the period of uncertainty could reasonably compound a consequential problem.

Pause the Smallest Set of Activities Necessary

A voluntary pause need not be all-or-nothing. Depending on the problem, researchers might stop new enrollment while continuing follow-up, stop one intervention while maintaining safety monitoring, suspend data transfer while continuing already approved participant visits, or pause activity at one affected site.

The scope should reflect the actual risk. Stopping everything can sometimes create its own problems, particularly for participants already receiving interventions or requiring follow-up.

Do Not Confuse Pausing Research With Abandoning Participants

A study pause can require continued participant contact and protective activity. Existing participants may need adverse-event monitoring, clinical evaluation, withdrawal procedures, referral, continued access to information, or other follow-up.

OHRP's current written-procedures guidance recommends that IRBs considering suspension or termination address participants already enrolled, including possible notification and orderly termination or transfer where appropriate. Although a researcher-initiated pause is not identical to an IRB suspension, the same participant-protection problem arises: stopping research activity should not mean disappearing on participants who still need appropriate management.

A Pause Does Not Replace Reporting

Voluntarily stopping enrollment does not satisfy a requirement to report an unanticipated problem, serious or continuing noncompliance, protocol deviation, safety event, or other reportable incident.

Under HHS requirements, institutions must have procedures for prompt reporting of unanticipated problems and serious or continuing noncompliance. Clinical trials may also have sponsor and regulatory reporting requirements.

Think of the pause as containment. Reporting, investigation, corrective action, participant communication, and prospective amendments remain separate tasks.

A Pause Should Have a Defined Question

“We paused because something felt wrong” is not enough to manage the study effectively. State what needs to be resolved before the affected activity can safely resume.

For example: Is the consent form materially deficient? Does the newly observed event increase research-related risk? Are eligibility checks functioning correctly? Has the data breach been contained? Can staff reliably implement the approved procedure? Does the protocol need amendment?

A clear question makes the pause purposeful rather than indefinite.

Resumption Should Follow Evidence, Not Schedule Pressure

Before restarting, determine whether the reason for pausing has actually been resolved. Corrective measures may include revised procedures, retraining, additional monitoring, new consent information, technical fixes, protocol amendments, or ethics review.

If the pause involved a matter requiring ethics approval, do not restart merely because the research team believes its proposed solution is adequate. Obtain the authorization required by the governing process.

Deadlines, funding milestones, student graduation schedules, and recruitment targets may create genuine pressure, but none demonstrates that the ethical problem has been solved. Calendars remain stubbornly unqualified to perform risk-benefit analysis.

When Unexpected Participant Distress Warrants Stopping Before the Next Recruitment

OHRP itself uses a behavioral-research example in which an unexpectedly strong psychological reaction to survey questions can constitute an unanticipated problem when it is related to the research and indicates greater risk than previously recognized.

Common Misunderstandings About Voluntarily Pausing Research

Use a Pause to Prevent the Problem From Becoming Larger While You Establish the Facts

A voluntary pause is most useful when it is targeted, documented, and connected to a specific unresolved concern. The objective is not to punish the research team. It is to avoid exposing additional participants or data to a problem whose significance has not yet been established.

A researcher-initiated pause differs from an ethics committee suspending or terminating approval. If the emerging problem is more fundamental, however, the next question is whether the ethical conditions under which the study was approved still hold.

When Considering a Voluntary Research Pause

Frequently Asked Questions About Voluntarily Pausing a Study

You Do Not Need to Wait for Someone Else to Order a Pause

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.